Kolon TissueGene
Blood & Organ Banks · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9713 Key West Ave Ste 300, Rockville, Ma...Phone Number
(301) 921-6000Website
www.tissuegene.comRevenue
$7.5 MillionIndustry
About Kolon TissueGene
Kolon TissueGene, Inc., is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee. Kolon TissueGene's lead product, TG-C, is an allogeneic cell and gene therapy. The Company has plans for two pivotal Phase III clinical trials in knee OA in the U.S., the first under a Special Protocol Assessment (SPA) agreement reached with the U.S. Food and Drug Administration (FDA).Explore more
Kolon TissueGene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Kolon TissueGene
Compare insights from companies similar to Kolon TissueGene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.2M
11-50
Private
<$5M
2013
TN
Tushar NuwalBusiness Corporate Development, Alliance Management & Commercial Strategy Head
Kolon TissueGene Tech Stack
A closer look at the technologies used by Kolon TissueGene
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kolon TissueGene
Sign Up For FreeTo access detailed company insights
Kolon TissueGene, Inc., is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee. Kolon TissueGene's lead product, TG-C, is an allogeneic cell and gene therapy. The Company has plans for two pivotal Phase III clinical trials in knee OA in the U.S., the first under a Special Protocol As... Read More
